Clinical Trial Update: A Study to Evaluate the Effects of Rifampin on Pharmacokinetics (PK) of Pevonedistat in Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the effect of rifampin on the pharmacokinetics of pevonedistat in participants with advanced solid tumors has completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Neoplasm
• Solid Tumor Cancer

Drugs mentioned

• Pevonedistat (pevonedistat)
• RIFAMPIN (RIFAMPIN)

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Advanced Solid Neoplasm | Phase 1 | Status: COMPLETED | Results posted: 2022-04-18